Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Breast Cancer
Interventions
DEVICE

OneMark device

"The OneMark device system consists of a tumor marker preloaded in a delivery system, a handheld probe, and a display console.~The OneMark marker is a metal clip with microparticles embedded in gelatin forming a hydrogel pellet. The pellet is implanted with a preloaded injector percutaneously in soft tissues, such as breast or lymph nodes, to mark a biopsy site or tissue intended for surgical removal. It can be used as a fiducial implant post-biopsy for future identification or monitoring of the tissue, and as an intra-operative localization mark. The microparticles of OneMark marker can be detected by Doppler ultrasound, magnetic resonance imaging (MRI), radiography, and OneMark Detector. During surgery, the OneMark marker may be removed with the target tissue. If patients do not require surgery, the OneMark marker can be left in place."

Trial Locations (1)

92093

University of California, San Diego, La Jolla

All Listed Sponsors
collaborator

View Point Medical

UNKNOWN

lead

University of California, San Diego

OTHER